Kura Oncology Inc (KURA) Stock Forecast & Price Target
Kura Oncology Inc · NASDAQ
$12.52-0.73 (-5.51%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Kura Oncology Inc, 9 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets range widely, $15.00 to $40.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $26.33 sits 110% above the current $12.52. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.78 next quarter toward $-2.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Strong Buy
Strong Buy00%
Buy9100%
Hold00%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Kura Oncology Inc.
As of Sep, 9 of 9 firms rate KURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.78
Range $-0.95 – $-0.68 · 9 analysts · -15% YoY
Next period, 9 analysts expect Kura Oncology Inc to earn $-0.78 a share (range $-0.95 – $-0.68), versus $-0.92 a year earlier. Full-year consensus is $-3.16, growing to $-2.30 the year after.
REVENUE · NEXT QUARTER
$33.5M
Range $20.3M – $91.1M · 9 analysts · +93% YoY
Revenue is expected to reach $33.5M (range $20.3M – $91.1M), +93.5% year-over-year. Full-year consensus is $96.6M, rising to $212.2M next year.
Top analysts covering Kura Oncology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KURA.
#1
Roger Song
Jefferies · Rank #101
Buy
$28.00+123.6% to target
Overall win rate
43%
+ Follow
#2
George Farmer
Scotiabank · Rank #240
Hold
$8.00-36.1% to target
Overall win rate
44%
+ Follow
#3
Li Watsek
Cantor Fitzgerald · Rank #275
Buy
No targeton KURA
Overall win rate
36%
+ Follow
#4
Joseph Pantginis
HC Wainwright & Co. · Rank #291
Buy
$40.00+219.5% to target
Overall win rate
34%
+ Follow
#5
Reni J. Benjamin
JMP Securities · Rank #366
Buy
$24.00+91.7% to target
Overall win rate
32%
+ Follow
KURA stock forecast FAQ
What is KURA's average 12-month price target?+
The 8 analysts with a live target average $26.33 for Kura Oncology Inc over the next 12 months, ranging from a $40.00 high to a $15.00 low.
Is KURA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 9 analyst ratings, 9 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KURA?+
The Street-high target is $40.00 (HC Wainwright & Co.), and the Street-low is $15.00 (UBS). The average of all 8 active targets is $26.33.
How many Wall Street analysts cover KURA?+
9 analysts have an active rating on Kura Oncology Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering KURA?+
Among analysts who currently cover KURA, Roger Song of Jefferies has the strongest overall Quantellect track record (Rank #101). Their current call is Buy with a $28.00 target.
What is Kura Oncology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.78 per share (range $-0.95 – $-0.68) across 9 analysts. Full-year EPS is projected at $-3.16, rising to $-2.30 the following year.
How much revenue is Kura Oncology Inc expected to report next quarter?+
Consensus revenue is $33.5M (range $20.3M – $91.1M). Full-year revenue is projected at $96.6M, growing to $212.2M next year.
Have analysts been upgrading or downgrading KURA lately?+
As of Sep, 9 of 9 firms rate KURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
